Data / Form D filings / Virocell Biologics Ltd
Virocell Biologics Ltd: Form D filing
Virocell Biologics Ltd, a biotechnology company in London, United Kingdom, filed a Form D with the SEC in 2022. The latest, on November 15, 2022, reports $992,645 sold of a $2.3 million offering to 4 investors.
Find out what Virocell Biologics Ltd does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- Vestry House, Laurence Pountney Hill, London, United Kingdom, EC4 O
- Phone
- 442045585438
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- United Kingdom
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1948363
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 15, 2022 | New notice | $2,337,500 | $992,645 | $1,344,855 | 4 | Nov 1, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Peter Eric Priestley | Director | |
| Farzin Eric Farzaneh | Executive Officer, Director | |
| Todd Christopher Davis | Director | |
| John Winthrop Hadden II | Executive Officer, Director | |
| J David Enloe Jr. | Director |
Every Form D from the week of Nov 14, 2022 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Virocell Biologics Ltd reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.